164 related articles for article (PubMed ID: 30917169)
1. Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
[TBL] [Abstract][Full Text] [Related]
2. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
[TBL] [Abstract][Full Text] [Related]
3. Dietary genistein inhibits metastasis of human prostate cancer in mice.
Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
[TBL] [Abstract][Full Text] [Related]
4. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
Lazarevic B; Hammarström C; Yang J; Ramberg H; Diep LM; Karlsen SJ; Kucuk O; Saatcioglu F; Taskèn KA; Svindland A
Br J Nutr; 2012 Dec; 108(12):2138-47. PubMed ID: 22397815
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
7. Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.
Craft CS; Xu L; Romero D; Vary CP; Bergan RC
Mol Pharmacol; 2008 Jan; 73(1):235-42. PubMed ID: 17951357
[TBL] [Abstract][Full Text] [Related]
8. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
[TBL] [Abstract][Full Text] [Related]
9. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
[TBL] [Abstract][Full Text] [Related]
11. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L; Bergan RC
Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
[TBL] [Abstract][Full Text] [Related]
12. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
13. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.
Pavese JM; Krishna SN; Bergan RC
Am J Clin Nutr; 2014 Jul; 100 Suppl 1(1):431S-6S. PubMed ID: 24871471
[TBL] [Abstract][Full Text] [Related]
14. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
[TBL] [Abstract][Full Text] [Related]
15. P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
Maynard JP; Lu J; Vidal I; Hicks J; Mummert L; Ali T; Kempski R; Carter AM; Sosa RY; Peiffer LB; Joshu CE; Lotan TL; De Marzo AM; Sfanos KS
J Pathol; 2022 Feb; 256(2):149-163. PubMed ID: 34652816
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase
Waldbillig F; Nitschke K; Abdelhadi A; von Hardenberg J; Nuhn P; Nientiedt M; Weis CA; Michel MS; Erben P; Worst TS
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575490
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
18. IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer.
Rohena-Rivera K; Sánchez-Vázquez MM; Aponte-Colón DA; Forestier-Román IS; Quintero-Aguiló ME; Martínez-Ferrer M
PLoS One; 2017; 12(4):e0172786. PubMed ID: 28379958
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
Li Y; Sarkar FH
Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
